1;Foreword;5 2;Contents of Volume 1;8 3;Contents of Volume 2;10 4;Contributors;13 5;Section VI - Tumors of the Genitalurinary System;21 5.1;18 Bladder Cancer;22 5.1.1;Epidemiology and Etiology;23 5.1.2;Anatomy;24 5.1.3;Pathology;26 5.1.4;Routes of Spread/Recurrence;27 5.1.4.1;Lymph Node Metastasis;28 5.1.5;Diagnosis, Staging, and Prognosis;29 5.1.5.1;Clinical Presentation;29 5.1.5.2;Diagnosis and Staging;30 5.1.5.3;Tumor, Node, and Metastasis Staging;30 5.1.5.4;Prognosis;32 5.1.6;Treatment;33 5.1.6.1;Principle and Practice;33 5.1.6.2;Treatment of Superficial Bladder Cancer;34 5.1.6.3;Treatment of Invasive Bladder Cancer;36 5.1.6.4;Definitive Surgical Intervention;37 5.1.6.5;Bladder Preservation;41 5.1.6.6;Treatment of Metastatic Bladder Cancer;49 5.1.7;Treatment of Non-urothelial Bladder Cancer;50 5.1.7.1;Treatment of Small Cell Carcinoma;50 5.1.7.2;Treatment of Squamous Cell Carcinoma;51 5.1.7.3;Treatment of Adenocarcinoma;51 5.1.8;Radiation Therapy Techniques;52 5.1.8.1;Simulation and Field Arrangements;52 5.1.9;Follow-Up;54 5.2;19 Prostate Cancer;56 5.2.1;Epidemiology and Etiology;57 5.2.2;Anatomy;58 5.2.3;Pathology;60 5.2.4;Routes of Spread;61 5.2.4.1;Lymph Node Metastasis;62 5.2.5;Diagnosis, Staging, and Prognosis;63 5.2.5.1;Clinical Presentation;63 5.2.5.2;Diagnosis and Staging;63 5.2.5.3;Tumor, Node, and Metastasis Staging;67 5.2.5.4;Prognoses;69 5.2.6;Treatment;70 5.2.6.1;Principles and Practice;70 5.2.6.2;Treatment of Localized Prostate Cancer;70 5.2.6.3;Adjuvant Radiation Therapy;85 5.2.6.4;Metastatic Prostate Cancer (T1-4, N0-1, M1);87 5.2.6.5;Treatment of Recurrent Prostate Cancer;87 5.2.7;Radiation Therapy Techniques;87 5.2.7.1;External Beam Radiation Therapy for Definitive Therapy;87 5.2.7.2;Interstitial LDR Brachytherapy;91 5.2.7.3;EBRT for Adjuvant Therapy;94 5.2.7.4;Normal Tissue Tolerance;97 5.2.8;Follow-Up;98 5.3;20 Testicular Cancer;99 5.3.1;Incidence and Genetics;100 5.3.2;Anatomy and Routes of Spread;101 5.3.3;Pathology;102 5.3.4;Clinical Presentation;103 5.3.5;Diagnosis, Staging, and Prognosis;104 5.3.5.1;Staging;106 5.3.5.2;Prognostic Factors;110 5.3.6;Treatment;110 5.3.6.1;Principles and Practice;110 5.3.6.2;Treatment for Stages I-II Seminoma;113 5.3.6.3;Treatment for Stages II-IV Seminoma;115 5.3.6.4;Treatment for Non-seminomatous Testicular Cancer;115 5.3.7;Radiation Therapy Techniques;116 5.3.7.1;Preparation and Simulation;116 5.3.7.2;Target Volumes and Doses;117 5.3.7.3;Normal Tissue Tolerance;122 5.3.8;Follow-Up;124 6;Section VII - Gynecological Cancers;126 6.1;21 Endometrial Cancer;127 6.1.1;Epidemiology and Etiology;128 6.1.2;Anatomy;128 6.1.3;Pathology;130 6.1.4;Routes of Spread;131 6.1.5;Diagnosis, Staging, and Prognosis;131 6.1.5.1;Clinical Presentation;131 6.1.5.2;Diagnosis;132 6.1.5.3;Tumor, Node, and Metastasis/Federation of Gynecology and Obstetrics Staging;132 6.1.5.4;Prognostic Factors;134 6.1.5.5;Principles and Practice;134 6.1.5.6;Treatment of Early-Stage Endometrial Cancer;134 6.1.5.7;Locoregionally Advanced Endometrial Cancer;139 6.1.5.8;Treatment of Less Common Histologic Subtypes;140 6.1.6;Radiation Therapy Techniques;141 6.1.6.1;Simulation and Field Arrangements;141 6.1.6.2;Dose and Treatment Delivery;141 6.1.6.3;Three-Dimensional Conformal Radiation Therapy and Intensity-Modulated Radiation Therapy, and Target Volume Delineation;142 6.1.6.4;Brachytherapy;144 6.1.7;Follow-Up;146 6.2;22 Cervical Cancer;147 6.2.1;Epidemiology and Etiology;148 6.2.2;Anatomy;148 6.2.3;Pathology;150 6.2.4;Routes of Spread;150 6.2.4.1;Lymphatic Spread;151 6.2.5;Diagnosis, Staging, and Prognosis;152 6.2.5.1;Clinical Presentation;152 6.2.5.2;Diagnosis and Pretherapy Evaluation;153 6.2.5.3;International Federation of Gynecology and Obstetrics, and Tumor, Node, and Metastasis Staging;154 6.2.5.4;Prognosis;157 6.2.6;Treatment;159 6.2.6.1;Principles and Practice;159 6.2.6.2;Treatment of Stage I-IIA (Resectable) Cervical Cancer;161 6.2.6.3;Treatment of Stage IIB-IVA Cervical Cancer;164 6.2.6.4;Treatment of Re